Acute kidney injury following coronary revascularization procedures in patients with advanced CKD.
acute kidney injury
chronic kidney disease
coronary artery bypass grafting
percutaneous coronary interventions
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402
Informations de publication
Date de publication:
01 11 2019
01 11 2019
Historique:
received:
23
02
2018
accepted:
12
05
2018
pubmed:
10
7
2018
medline:
15
4
2020
entrez:
10
7
2018
Statut:
ppublish
Résumé
Previous studies reported that compared with percutaneous coronary interventions (PCIs), coronary artery bypass grafting (CABG) is associated with a reduced risk of mortality and repeat revascularization in patients with mild to moderate chronic kidney disease (CKD) and end-stage renal disease (ESRD). Information about outcomes associated with CABG versus PCI in patients with advanced stages of CKD is limited. We evaluated the incidence and relative risk of acute kidney injury (AKI) associated with CABG versus PCI in patients with advanced CKD. We examined 730 US veterans with incident ESRD who underwent a first CABG or PCI up to 5 years prior to dialysis initiation. The association of CABG versus PCI with AKI was examined in multivariable adjusted logistic regression analyses. A total of 466 patients underwent CABG and 264 patients underwent PCI. The mean age was 64 ± 8 years, 99% were male, 20% were African American and 84% were diabetic. The incidence of AKI in the CABG versus PCI group was 67% versus 31%, respectively (P < 0.001). The incidence of all stages of AKI were higher after CABG compared with PCI. CABG was associated with a 4.5-fold higher crude risk of AKI {odds ratio [OR] 4.53 [95% confidence interval (CI) 3.28-6.27]; P < 0.001}, which remained significant after multivariable adjustments [OR 3.50 (95% CI 2.03-6.02); P < 0.001]. CABG was associated with a 4.5-fold higher risk of AKI compared with PCI in patients with advanced CKD. Despite other benefits of CABG over PCI, the extremely high risk of AKI associated with CABG should be considered in this vulnerable population when deciding on the optimal revascularization strategy.
Sections du résumé
BACKGROUND
Previous studies reported that compared with percutaneous coronary interventions (PCIs), coronary artery bypass grafting (CABG) is associated with a reduced risk of mortality and repeat revascularization in patients with mild to moderate chronic kidney disease (CKD) and end-stage renal disease (ESRD). Information about outcomes associated with CABG versus PCI in patients with advanced stages of CKD is limited. We evaluated the incidence and relative risk of acute kidney injury (AKI) associated with CABG versus PCI in patients with advanced CKD.
METHODS
We examined 730 US veterans with incident ESRD who underwent a first CABG or PCI up to 5 years prior to dialysis initiation. The association of CABG versus PCI with AKI was examined in multivariable adjusted logistic regression analyses.
RESULTS
A total of 466 patients underwent CABG and 264 patients underwent PCI. The mean age was 64 ± 8 years, 99% were male, 20% were African American and 84% were diabetic. The incidence of AKI in the CABG versus PCI group was 67% versus 31%, respectively (P < 0.001). The incidence of all stages of AKI were higher after CABG compared with PCI. CABG was associated with a 4.5-fold higher crude risk of AKI {odds ratio [OR] 4.53 [95% confidence interval (CI) 3.28-6.27]; P < 0.001}, which remained significant after multivariable adjustments [OR 3.50 (95% CI 2.03-6.02); P < 0.001].
CONCLUSION
CABG was associated with a 4.5-fold higher risk of AKI compared with PCI in patients with advanced CKD. Despite other benefits of CABG over PCI, the extremely high risk of AKI associated with CABG should be considered in this vulnerable population when deciding on the optimal revascularization strategy.
Identifiants
pubmed: 29986054
pii: 5049870
doi: 10.1093/ndt/gfy178
pmc: PMC7967886
doi:
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1894-1901Subventions
Organisme : NIDDK NIH HHS
ID : K24 DK091419
Pays : United States
Organisme : HSRD VA
ID : SDR 02-237
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK102163
Pays : United States
Informations de copyright
Published by Oxford University Press on behalf of ERA-EDTA 2018. This work is written by US Government employees and is in the public domain in the US.
Références
Kidney Int Suppl. 2003 Nov;(87):S24-31
pubmed: 14531770
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1428-1437
pubmed: 28679562
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Acta Anaesthesiol Scand. 2016 Oct;60(9):1230-40
pubmed: 27378715
Am J Cardiol. 2017 May 15;119(10):1507-1511
pubmed: 28341354
Ann Thorac Surg. 2009 Feb;87(2):489-95
pubmed: 19161766
Lancet. 2013 Feb 23;381(9867):639-50
pubmed: 23439103
Ann Thorac Surg. 2007 Nov;84(5):1496-502
pubmed: 17954051
J Am Coll Cardiol. 2017 May 2;69(17):2212-2241
pubmed: 28291663
Ann Intern Med. 1998 Feb 1;128(3):194-203
pubmed: 9454527
N Engl J Med. 2012 Dec 20;367(25):2375-84
pubmed: 23121323
Am J Kidney Dis. 2004 Jan;43(1):1-9
pubmed: 14712421
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8
pubmed: 28236831
Arch Intern Med. 2011 Feb 14;171(3):226-33
pubmed: 21325112
Ann Thorac Surg. 2016 May;101(5):1655-62
pubmed: 27041450
Circulation. 2010 Jan 26;121(3):357-65
pubmed: 20065168
Crit Care. 2013 Feb 04;17(1):204
pubmed: 23394211
Circ Cardiovasc Interv. 2014 Apr;7(2):190-8
pubmed: 24569598
Circulation. 2015 Oct 27;132(17):1667-78
pubmed: 26503749
Rev Bras Cir Cardiovasc. 2013 Jun;28(2):231-7
pubmed: 23939320
J Am Coll Cardiol. 2014 Sep 9;64(10):985-94
pubmed: 25190232
JAMA. 2014 Jun 4;311(21):2191-8
pubmed: 24886787
Am J Kidney Dis. 2016 Jun;67(6):872-80
pubmed: 26337133
Circulation. 2015 Oct 20;132(16):1538-48
pubmed: 26384521
Am J Kidney Dis. 2006 Sep;48(3):392-401
pubmed: 16931212
Am Fam Physician. 2002 Oct 15;66(8):1471-6, 1379
pubmed: 12408421
Crit Care. 2016 Jul 04;20(1):187
pubmed: 27373799
J Am Soc Nephrol. 2012 Dec;23(12):2042-9
pubmed: 23204445
Kidney Int. 2010 Oct;78(8):803-9
pubmed: 20686453
Nephrol Dial Transplant. 2010 Nov;25(11):3654-63
pubmed: 20551089
Circulation. 2009 May 12;119(18):2444-53
pubmed: 19398670
Am J Cardiol. 2014 Sep 15;114(6):820-5
pubmed: 25073568
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Ann Thorac Surg. 2008 Aug;86(2):496-503; discussion 503
pubmed: 18640323
Kidney Int. 2011 Jun;79(12):1361-9
pubmed: 21430640
Nephrol Dial Transplant. 2008 Jun;23(6):1970-4
pubmed: 18178605
Clin J Am Soc Nephrol. 2010 Oct;5(10):1734-44
pubmed: 20671222
Acta Anaesthesiol Scand. 2017 Oct;61(9):1075-1083
pubmed: 28748536
N Engl J Med. 2012 Apr 19;366(16):1467-76
pubmed: 22452338
Clin J Am Soc Nephrol. 2006 Jan;1(1):19-32
pubmed: 17699187
JACC Cardiovasc Interv. 2010 Oct;3(10):1059-67
pubmed: 20965465
Am J Nephrol. 2017;45(3):217-225
pubmed: 28135709
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
J Am Heart Assoc. 2014 Dec;3(6):e001380
pubmed: 25516439
Kidney Int. 2016 Aug;90(2):411-421
pubmed: 27259368
Circulation. 2014 Dec 2;130(23):2005-11
pubmed: 25239439
J Am Heart Assoc. 2016 Oct 14;5(10):
pubmed: 27742616